1 This insulin secretion causes an overall decrease in blood sugar levels, reduces the production of glucagon, which prevents the release of glucose storage from the liver, and induces a satiety response that elevates insulin sensitivity and causes weight loss
Compounded drugs are not FDA-approved, and the agency does not verify the safety or effectiveness of compounded drugs
(See Adverse effects .) Adverse effects Potential adverse effects of semaglutide and their underlying mechanisms include the following: Acute kidney injury The exact mechanism for this adverse effect is unknown
Hyperalgesia is an increased pain response to stimuli that do normally cause pain, such as a pinch hurting far more than expected
This extended presence triggers stronger satiety signals, often manifesting as nausea or cramping
It is licensed for weight loss, and is easier to administer the recommended dosages for maximum benefit